Canopy Growth Corporation (CGC) Stock Price, News, Quote & History

Nov 3, 2024
canopy-growth-corporation-(cgc)-stock-price,-news,-quote-&-history

We are experiencing some temporary issues. The market data on this page is currently delayed. Please bear with us as we address this and restore your personalized lists.

NasdaqGS – Delayed Quote USD

4.8600 +0.2700 (+5.88%)

At close: November 1 at 4:00 PM EDT

4.9190 +0.06 (+1.21%)

After hours: November 1 at 7:52 PM EDT

  • Previous Close 4.5900
  • Open 4.7000
  • Bid 4.8500 x 2500
  • Ask 4.9000 x 3800
  • Day’s Range 4.6400 – 4.9400
  • 52 Week Range 2.7550 – 14.9200
  • Volume 4,408,785
  • Avg. Volume 4,072,092
  • Market Cap (intraday) 541.389M
  • Beta (5Y Monthly) 1.79
  • PE Ratio (TTM)
  • EPS (TTM) -5.6900
  • Earnings Date Nov 8, 2024
  • Forward Dividend & Yield
  • Ex-Dividend Date
  • 1y Target Est 4.09

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

www.canopygrowth.com

1,029

Full Time Employees

March 31

Fiscal Year Ends

View More

Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

S&P/TSX Composite index

15.73%

1-Year Return

S&P/TSX Composite index

28.51%

3-Year Return

S&P/TSX Composite index

15.30%

5-Year Return

S&P/TSX Composite index

47.15%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

View More

Valuation Measures

As of 11/1/2024

  • Market Cap

    413.44M

  • Enterprise Value

    720.99M

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

    1.90

  • Price/Book (mrq)

    1.08

  • Enterprise Value/Revenue

    3.50

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -259.94%

  • Return on Assets (ttm)

    -3.83%

  • Return on Equity (ttm)

    -87.26%

  • Revenue (ttm)

    287.1M

  • Net Income Avi to Common (ttm)

    -602.3M

  • Diluted EPS (ttm)

    -5.6900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    196.92M

  • Total Debt/Equity (mrq)

    117.00%

  • Levered Free Cash Flow (ttm)

    17.19M

View More

Earnings Per Share

 

Revenue vs. Earnings

 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

 

Analyst Price Targets

 

CGC does not have Company Insights

View More
  • Canopy Growth: CEO David Klein to Retire; Search for Replacement Has Begun

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company’s financials.

     

  • Canopy Earnings: Shares Look Fairly Valued as Cannabis Positions Are Middling

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company’s financials.

     

  • US Deals Help Unlock Some Value but Doesn’t Help Canopy Growth’s Lagging Canadian Operations

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth merged its US assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company’s financials.

     

  • Canopy Earnings: Losses Narrow and Near-Term Dilution Risk Falls, but Shares Fairly Valued

    Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include skincare products under Martha Stewart CBD and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company’s financials.

     

Leave a comment